JZYY(SH:600750) Zheng Quan Zhi Xing·2025-09-01 11:08Core Viewpoint - Jiangzhong Pharmaceutical Co., Ltd. is holding its first extraordinary general meeting of shareholders in 2025 to discuss key proposals including the profit distribution plan for the first half of 2025 and the reappointment of the auditing firm for the year [1][4]. Meeting Procedures - The meeting will be conducted in accordance with relevant laws and regulations to ensure the rights of shareholders and maintain order [1][2]. - Only authorized shareholders and specific invited personnel are allowed to attend the meeting, and registration is required prior to the meeting [1][2]. - Shareholders have the right to speak, inquire, and vote, but must register to speak in advance and adhere to time limits [2][3]. Meeting Agenda - The meeting is scheduled for September 8, 2025, at 14:50 in Nanchang, Jiangxi Province [1][4]. - The agenda includes the profit distribution plan for the first half of 2025 and a proposal to reappoint KPMG Huazhen as the auditing firm for 2025 [1][4]. Profit Distribution Plan - The company proposes a cash dividend of 5 yuan (including tax) for every 10 shares, which amounts to a total distribution of approximately 317.5 million yuan based on the total share capital of 634,996,022 shares as of June 2025 [4][5]. - This cash dividend represents 60.78% of the net profit attributable to the parent company for the first half of 2025 [4][5]. Auditing Firm Reappointment - The company intends to reappoint KPMG Huazhen as its auditing firm for 2025, ensuring continuity and stability in audit services [6][8]. - KPMG Huazhen has a strong track record, with over 41 billion yuan in total revenue for 2024, of which over 40 billion yuan was from audit services [6][7]. - The firm has audited 127 listed companies in 2024, with a total audit fee of approximately 682 million yuan [7][8].